Hypothesis

Nucleocytoplasmic transport failure in aged cholinergic basal forebrain neurons (BFCNs) impairs the import of RanBP2 and other nucleoporins, leading to defective kinesin‑1‑mediated retrograde trafficking of NGF‑TrkA complexes and concomitant loss of ChAT expression.

Mechanistic Rationale

• Aging BFCNs show reduced HP1γ and increased DNA damage, indicating heterochromatin loss and altered nuclear envelope composition 3.
• Heterochromatin loss can change the phosphorylation state of nucleoporins such as RanBP2 (Nup358), a key component of the cytoplasmic filament of the nuclear pore complex that also serves as a scaffold for kinesin‑1 light chains 1.
• When RanBP2 is hypophosphorylated, its affinity for kinesin‑1 decreases, slowing retrograde transport of NGF‑TrkA endosomes along microtubules.
• Simultaneously, impaired import of transcription factors (e.g., REST, Nurr1) that drive ChAT gene expression reduces cholinergic phenotype, creating a feed‑forward loop.
• Tau hyperphosphorylation, observed in patient‑derived BFCNs 3, can activate CDK5, which phosphorylates nucleoporins and further disrupts the Ran gradient.

Testable Predictions

1. Phosphorylation state of RanBP2 correlates with NGF retrograde speed – In aged BFCNs, RanBP2 will show decreased phospho‑serine/threonine residues and slower NGF‑TrkA vesicle velocities compared with young cells.
2. Restoring RanBP2 phosphorylation rescues both transport and ChAT – Pharmacological activation of Src family kinases (which phosphorylate RanBP2) or expression of a phosphomimetic RanBP2 mutant will increase retrograde NGF flux and ChAT mRNA/protein levels.
3. Inhibiting CDK5 ameliorates the defect – CDK5 inhibition in aged BFCNs will normalize RanBP2 phosphorylation, improve nucleocytoplasmic import of HP1γ, and restore NGF transport.
4. Nucleocytoplasmic import of HP1γ is required for ChAT maintenance – Knockdown of importin‑β1 will reduce nuclear HP1γ, decrease ChAT expression, and exacerbate NGF transport deficits even if RanBP2 is phosphomimetic.

Experimental Approach

• Use iPSC‑derived human BFCNs from young, aged, and AD donors (as in 3).
• Live‑cell imaging of fluorescently tagged NGF‑TrkA to quantify retrograde velocity and run length.
• Western blot and phospho‑specific antibodies to assess RanBP2 phosphorylation status.
• Manipulate RanBP2 via CRISPR knock‑in of phosphomimetic (S/E) or phospho‑dead (A) mutants, and treat with Src activator (PP2 withdrawal) or CDK5 inhibitor (roscovitine).
• Measure ChAT mRNA (qPCR) and protein (immunocytochemistry), HP1γ nuclear localization (immunofluorescence), and nucleocytoplasmic transport of a NLS‑GFP reporter.
• Behavioral correlation: transplant edited BFCNs into aged rat basal forebrain and assess spatial memory in Morris water maze 2.

If the data show that restoring RanBP2 phosphorylation simultaneously improves NGF retrograde transport and ChAT expression, the hypothesis is supported. Conversely, if manipulating RanBP2 phosphorylation fails to affect either phenotype, the hypothesis is falsified.